| Literature DB >> 31099931 |
Haibo Mei1, Jianlin Han1, Santos Fustero2,3, Mercedes Medio-Simon2,3, Daniel M Sedgwick2,3, Claudio Santi4, Renzo Ruzziconi5, Vadim A Soloshonok6,7.
Abstract
Over the last two decades, fluorine substitution has become one of the essential structural traits in modern pharmaceuticals. Thus, about half of the most successful drugs (blockbuster drugs) contain fluorine atoms. In this review, we profile 17 fluorine-containing drugs approved by the food and drug administration (FDA) in 2018. The newly approved pharmaceuticals feature several types of aromatic F and CF3 , as well as aliphatic (CF2 ) substitution, offering advances in the treatment of various diseases, including cancer, HIV, malarial and smallpox infections.Entities:
Keywords: HIV; biochemistry; cancer; fluorine; substitution reactions
Mesh:
Substances:
Year: 2019 PMID: 31099931 DOI: 10.1002/chem.201901840
Source DB: PubMed Journal: Chemistry ISSN: 0947-6539 Impact factor: 5.236